These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30069789)

  • 1. The tetraamine chelator outperforms HYNIC in a new technetium-99m-labelled somatostatin receptor 2 antagonist.
    Abiraj K; Ursillo S; Tamma ML; Rylova SN; Waser B; Constable EC; Fani M; Nicolas GP; Reubi JC; Maecke HR
    EJNMMI Res; 2018 Aug; 8(1):75. PubMed ID: 30069789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPECT Imaging of SST2-Expressing Tumors with
    Gaonkar RH; Wiesmann F; Del Pozzo L; McDougall L; Zanger S; Mikołajczak R; Mansi R; Fani M
    Pharmaceuticals (Basel); 2021 Mar; 14(4):. PubMed ID: 33800582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
    J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of the First
    Fani M; Weingaertner V; Kolenc Peitl P; Mansi R; Gaonkar RH; Garnuszek P; Mikolajczak R; Novak D; Simoncic U; Hubalewska-Dydejczyk A; Rangger C; Kaeopookum P; Decristoforo C
    Pharmaceuticals (Basel); 2020 Dec; 14(1):. PubMed ID: 33379299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
    Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
    Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.
    Fani M; Del Pozzo L; Abiraj K; Mansi R; Tamma ML; Cescato R; Waser B; Weber WA; Reubi JC; Maecke HR
    J Nucl Med; 2011 Jul; 52(7):1110-8. PubMed ID: 21680701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.
    Decristoforo C; Mather SJ
    Eur J Nucl Med; 1999 Aug; 26(8):869-76. PubMed ID: 10436200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor targeting with hydrophilic [
    Makris G; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
    Nucl Med Biol; 2019 Apr; 71():39-46. PubMed ID: 31129499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of a
    Radford L; Gallazzi F; Watkinson L; Carmack T; Berendzen A; Lewis MR; Jurisson SS; Papagiannopoulou D; Hennkens HM
    Nucl Med Biol; 2017 Apr; 47():4-9. PubMed ID: 28043006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of Re/
    Radford LL; Papagiannopoulou D; Gallazzi F; Berendzen A; Watkinson L; Carmack T; Lewis MR; Jurisson SS; Hennkens HM
    Bioorg Med Chem; 2019 Feb; 27(3):492-501. PubMed ID: 30594453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
    Yu F; Lü ML; Zhang XP; Fu D; Hou M; Cai HD; Li D; Wang J; Yuan XY; Lü ZW; Dong F
    Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, preparation and biological evaluation of a
    Behnammanesh H; Jokar S; Erfani M; Geramifar P; Sabzevari O; Amini M; Mazidi SM; Hajiramezanali M; Beiki D
    Bioorg Chem; 2020 Jan; 94():103381. PubMed ID: 31662215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, radiolabeling and evaluation of [
    Dinmohammadi F; Erfani M; Shamsaei M; Shirmardi SP; Goudarzi M
    Bioorg Chem; 2023 Jan; 130():106237. PubMed ID: 36402025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
    Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F
    Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.
    Abiraj K; Mansi R; Tamma ML; Fani M; Forrer F; Nicolas G; Cescato R; Reubi JC; Maecke HR
    J Nucl Med; 2011 Dec; 52(12):1970-8. PubMed ID: 22080443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
    Wild D; Wicki A; Mansi R; Béhé M; Keil B; Bernhardt P; Christofori G; Ell PJ; Mäcke HR
    J Nucl Med; 2010 Jul; 51(7):1059-67. PubMed ID: 20595511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
    Guo H; Miao Y
    J Nucl Med; 2014 Dec; 55(12):2057-63. PubMed ID: 25453052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours.
    von Guggenberg E; Dietrich H; Skvortsova I; Gabriel M; Virgolini IJ; Decristoforo C
    Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1209-18. PubMed ID: 17308920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive evaluation of a somatostatin-based radiolabelled antagonist for diagnostic imaging and radionuclide therapy.
    Wang X; Fani M; Schulz S; Rivier J; Reubi JC; Maecke HR
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1876-85. PubMed ID: 22926735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.